BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33687665)

  • 1. Assessment of previous fracture and anti-osteoporotic medication prescription in hip fracture patients.
    McCarthy CJ; Kelly MA; Kenny PJ
    Ir J Med Sci; 2022 Feb; 191(1):247-252. PubMed ID: 33687665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
    Wang X; Li C; He Y; Wang T; Zhang H; Ma Z; Ma H; Zhao H
    Arch Osteoporos; 2020 Aug; 15(1):134. PubMed ID: 32820451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hip fracture and osteoporosis medication prescription rates across Canadian provinces.
    Crilly RG; Kloseck M; Chesworth B; Mequanint S; Sadowski E; Gilliland J
    Osteoporos Int; 2014 Jan; 25(1):205-10. PubMed ID: 23907572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
    Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
    JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Beall DP; Feldman RG; Gordon ML; Gruber BL; Lane JM; Valenzuela G; Yim D; Alam J; Krege JH; Krohn K
    Osteoporos Int; 2016 Mar; 27(3):1191-1198. PubMed ID: 26556737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
    Cheung MY; Ho AW; Wong SH
    Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
    Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
    Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
    Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
    Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimates of hip fracture incidence in Japan using the National Health Insurance Claim Database in 2012-2015.
    Tamaki J; Fujimori K; Ikehara S; Kamiya K; Nakatoh S; Okimoto N; Ogawa S; Ishii S; Iki M;
    Osteoporos Int; 2019 May; 30(5):975-983. PubMed ID: 30648192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualisation of the unmet treatment need of osteoporotic fracture in Taiwan: A nationwide cohort study.
    Wang CY; Fu SH; Huang CC; Hung CC; Yang RS; Hsiao FY
    Int J Clin Pract; 2018 Oct; 72(10):e13246. PubMed ID: 30144247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
    Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y
    Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
    Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
    Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study.
    González-Quevedo D; Pérez-Del-Río V; Moriel-Garceso D; Fernández-Arroyabe N; García-Meléndez G; Montañez-Ruiz M; Bravo-Bardají M; García-de-Quevedo D; Tamimi I
    Osteoporos Int; 2022 Aug; 33(8):1695-1702. PubMed ID: 35357521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
    Bone; 2023 Jan; 166():116605. PubMed ID: 36347433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures.
    Weycker D; Edelsberg J; Barron R; Atwood M; Oster G; Crittenden DB; Grauer A
    Osteoporos Int; 2017 Sep; 28(9):2565-2571. PubMed ID: 28593447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiresorptive treatment, when initiated after a first hip fracture, may not protect of a second contralateral episode in elderly population: A study with 685 patients.
    Besalduch M; Carrera I; Gómez-Masdeu M; De Caso J
    Injury; 2016 Apr; 47(4):877-80. PubMed ID: 26892501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an in-hospital, surgeon-led anti-osteoporotic medication algorithm in patients with hip fractures improves persistence to medication and can prevent the second fragility fracture.
    Daskalakis II; Kritsotakis EI; Karantanas AH; Kontakis GM; Bastian JD; Tosounidis TH
    Arch Orthop Trauma Surg; 2024 Feb; 144(2):683-692. PubMed ID: 38044337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between osteoporosis medications and lowered all-cause mortality after hip or vertebral fracture in older and oldest-old adults: a nationwide population-based study.
    Li CC; Hsu JC; Liang FW; Chang YF; Chiu CJ; Wu CH
    Aging (Albany NY); 2022 Mar; 14(5):2239-2251. PubMed ID: 35232893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
    Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
    Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undertreatment of osteoporosis following hip fracture: a retrospective, observational study in Singapore.
    Chau YT; Nashi N; Law LS; Goh RKH; Choo SX; Seetharaman SK
    Arch Osteoporos; 2020 Sep; 15(1):141. PubMed ID: 32918196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.